In addition, the up-regulation of this miRNA in GDM patients in the second trimester of gestation has demonstrated a correlation with the down-regulation of IRS1 and IRS2, leading to abnormal signaling of the Wnt/β-catenin pathway, important for embryonic development and adult tissue homeostasis [77]. The gene discussed is IRS1; the disease is gestational diabetes.